Applied Spectral Imaging (ASI) is a global leader in biomedical imaging solutions for Pathology, Cytogenetics, and Life Sciences. Since 1993, ASI has developed advanced imaging platforms that streamline diagnostic workflows – from image acquisition to quantitative analysis, reporting, and LIS integration. With over 5,000 systems installed in more than 80 countries, ASI’s technology enhances accuracy and efficiency in karyotyping, FISH, digital pathology, IHC, and spectral imaging.
Now part of ZYTOMICS, a leader in cancer diagnostics, ASI combines its digital imaging expertise with ZYTOMICS’ automation and reagent capabilities to offer comprehensive end-to-end laboratory solutions. Probe-agnostic and scanner-agnostic, ASI provides the flexibility labs need to work with their preferred protocols.
With FDA-cleared and IVDR-compliant products, a strong global presence, and outstanding support, ASI continues to set the standard in diagnostic imaging – advancing patient care with innovative, reliable, and future-ready solutions.
Together, ZYTOMICS and ASI combine a broad reagent portfolio with advanced digital imaging – because Every Diagnosis Counts.
Our mission is to equip pathology and cytogenetic laboratories worldwide with state-of-the-art biomedical imaging solutions powered by cutting-edge technologies and computer-aided workflows, aiming to reduce turnaround time while addressing the growing challenge of increased sample volumes.
Limor Shiposh has been with ASI for over two decades, having joined in 1999 and subsequently taking the helm as CEO in 2002, where she leads to this day.
Before joining ASI, Limor occupied prominent positions from 1988-1990 at the Ministry of Defense Procurement Office in New York, notably as Assistant to the Deputy Internal Auditor. She further showcased her leadership over the next 10 years as Controller and CFO for Rada Electronics Industries Ltd., a NASDAQ-listed entity with branches in the USA, Europe, and the Far East.
Limor holds a BA in Economics & Business Administration and an MBA (Summa Cum Laude) from the New York Institute of Technology.
Yaniv Giron has vast financial experience and expertise leading companies towards organic and inorganic growth.
For the past 16 years, he served as the CFO in several technological and commercial companies.
In addition to his CPA license, he holds an MBA in Business Administration, and a B.A. in Management and Accounting, from the College of Management.
Nir Katzir was a member of ASI’s founding team in 1993.
Since then, he has managed key projects and played a major role in the design and the development of ASI’s unique products and applications.
As an ASI executive he led the Research and Development activities, he was in charge of the algorithms that form the backbone of the company’s intellectual property.
He is the co-author of many of ASI’s patents and publications. Prior to 1993, Mr. Katzir worked on a Ph.D. at a prestigious Institute of Technology.
He received his MSc degree in Electrical Engineering and BSc degree in Computer Engineering, both summa cum laude. He specialized in computer vision, image analysis, spectral and multi-dimensional imaging.
Mr. Katzir was awarded several prizes, fellowships and honors, such as the P.Martin Excellence award, the Ollendorf award for excellence in the field of image analysis, the Jury award, the Gutvirt Scholarship, and many teaching awards.
Yuval Ben Zeev joined ASI in 2016 as a Project Manager.
Prior to joining ASI, Yuval worked at Carestream Ltd (formerly Orex Computed Radiography) as a Software Manager leading all software related activities as well as system-wide tasks.
Yuval has more than 23 years of experience successfully delivering a wide-range and global state-of-the art healthcare software products (Medical & Dental Computer Radiography, Nuclear medicine scanners, Hybrid NM-CT scanners, etc.)
Yuval holds a BsC degree in Computer Engineering from the Technion Israel Institute of Technology and a PMP certification from the Project Management Institute (PMI).
Dr. Yael Glickman has 20 years of international experience in the Medical Device and Biotech industries.
Throughout her career, Yael served in various managerial positions in R&D;, Marketing, and Business Development. Before joining ASI, Yael was responsible for the oncology and neurology portfolio strategy for the Advanced Visualization business at Philips Healthcare.
During her 5-year tenure at Philips, she contributed to the introduction of AI-based algorithms in the Radiology Imaging software portfolio.
Dr. Glickman holds a Ph.D. in Chemistry from the Weizmann Institute, an MBA from the Technion Institute of Technology, and an Engineering degree from CPE-Lyon.
Michal Hayun joined ASI in 2016 and worked as HR Specialist and recruiter, for several years.
Prior to joining ASI, Michal worked at “Olympus” (CBYOND), a Medical Device global company, in an HR and recruiting position.
Michal specializes in Human Recourses cross-organization strategic planning, recruiting, welfare and wellbeing.
Michal holds an MA degree in organizational development from the University of Haifa, Israel.
Gabriel Jarczun is a highly experienced professional with 23 years of expertise in the software industry.
He holds an MSc. in computer engineering and an MBA in Healthcare Innovation.
In 2022, Gabriel joined ASI, bringing his wealth of knowledge to the company’s high-performing teams.
He is responsible for integrating cutting-edge AI and Cloud technologies into ASI’s next generation of products.
Throughout his career, he has played a key role in developing innovative solutions for various domains. With a focus on medical software, Gabriel has made significant contributions to previous companies he worked for in the field of medical diagnostics.
Dr. Irit Bar-Am joined ASI in 1996.
Irit is responsible for the development and production of our molecular probe kits. She also plays a key role in developing new applications in cytogenetics and pathology and conducting clinical utility studies.
With over thirty publications, she is considered an expert in FISH (fluorescent in situ hybridization), a technique that has revolutionized both research and clinical analysis in cytogenetics.
Irit holds a Ph.D. in Human Genetics.
Limor Shiposh has been with ASI for over two decades, having joined in 1999 and subsequently taking the helm as CEO in 2002, where she leads to this day.
Before joining ASI, Limor occupied prominent positions at the Ministry of Defense Procurement Office in New York, at the Internal Auditor office. She further showcased her leadership over the next 10 years as CFO for Rada Electronics Industries Ltd., a NASDAQ-listed entity.
Limor holds a BA in Economics & Business Administration and an MBA (Summa Cum Laude) from the New York Institute of Technology.